FDA Clearance Tracker · P830055-S334
Attune Primary System
Last checked: Nov 20, 2026Latest source record: Feb 20, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 20, 2025
Approved
Time to decision
146 days
Received Sep 27, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P830055-S334
- Device name
- Attune Primary System
- Applicant
- Depuy, Inc.
- Applicant location
- Warsaw, IN
- Received
- Sep 27, 2024
- Decided
- Feb 20, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P830055
Device type
- Device type
- Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for two changes: i) change in the manufacturing consolidation process of antioxidant (Pentaerythritol tetrakis [3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate]) (AOX), Ultra-High Molecular Weight Polyethylene (UHMWPE) bar stock material for the Attune Cruciate Retaining Rotating Platform (CR RP) and the Attune Posterior Stabilized Rotating Platform (PS RP) tibial inserts components that belong to the Attune Primary System.ii) change in the sterilization process of the Attune Cruciate Retaining Rotating Platform (CR RP), Attune Posterior Stabilized Rotating Platform (PS RP) tibial inserts components and the Attune Medialized Anatomic and Medialized Dome Patellar Components that belong to the Attune Primary System from a single, high dose sterilization to a split-dose sterilization method through a combination of crosslinking AOX UHMWPE raw material and final terminal sterilization
Source documents
Other decisions for Depuy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.